28062147|t|Periprocedural myocardial infarction during percutaneous coronary intervention in an academic tertiary centre in Johannesburg
28062147|a|Percutaneous coronary intervention (PCI) is effective therapy for significant atherosclerotic coronary artery disease. Despite medical and technological advances in PCI, periprocedural myocardial infarction (PMI) remains a common complication. The frequency and factors associated with PMI have been well investigated in the developed world, yet there is a paucity of data from the developing world, especially Sub-Saharan Africa. We prospectively enrolled 153 adult patients undergoing PCI at the Charlotte Maxeke Johannesburg Academic Hospital from the 1st of February 2014 to 31st October 2014. Periprocedural Creatinine Kinase-MB and hs-Troponin I were routinely measured before PCI and at 16-24h post-procedure. The third universal definition of myocardial infarction was used to define a PMI event. 152 participants met the inclusion criteria and were analysed for PMI. 70.4% participants were male. The mean age was 58.8 (SD 10.9) years old. Sixteen (10.5%) participants fulfilled the criteria for PMI. Side branch pinching with preserved TIMI III flow was noted in 62.5% of PMI cases. Duration of procedure (P=0.007), right coronary artery intervention (p=0.042) and total stent length (p=0.045) were independently associated with PMI. PMI occurred in 10.5% of cases undergoing PCI. This is consistent with the prevalence of PMI internationally. Larger multicentre studies are required in our demographic region to further define relevant predictors and outcomes associated with PMI.
28062147	0	36	Periprocedural myocardial infarction	T047	C3839342
28062147	44	78	percutaneous coronary intervention	T061	C1532338
28062147	85	109	academic tertiary centre	T073,T093	C0587437
28062147	113	125	Johannesburg	UnknownType	C0681784
28062147	126	160	Percutaneous coronary intervention	T061	C1532338
28062147	162	165	PCI	T061	C1532338
28062147	170	179	effective	T080	C1704419
28062147	180	187	therapy	T061	C0087111
28062147	192	203	significant	T078	C0750502
28062147	204	243	atherosclerotic coronary artery disease	T047	C0010054
28062147	253	260	medical	T169	C0205476
28062147	265	287	technological advances	UnknownType	C0681519
28062147	291	294	PCI	T061	C1532338
28062147	296	332	periprocedural myocardial infarction	T047	C3839342
28062147	334	337	PMI	T047	C3839342
28062147	356	368	complication	T046	C0009566
28062147	374	383	frequency	T079	C0376249
28062147	388	395	factors	T169	C1521761
28062147	396	411	associated with	T080	C0332281
28062147	412	415	PMI	T047	C3839342
28062147	431	443	investigated	T169	C1292732
28062147	451	466	developed world	T098	C2700280
28062147	494	498	data	T078	C1511726
28062147	508	524	developing world	T098	C2700280
28062147	537	555	Sub-Saharan Africa	T083	C0001738
28062147	587	592	adult	T100	C0001675
28062147	593	601	patients	T101	C0030705
28062147	613	616	PCI	T061	C1532338
28062147	624	671	Charlotte Maxeke Johannesburg Academic Hospital	T073,T093	C0019994
28062147	724	738	Periprocedural	T046	C1141861
28062147	739	759	Creatinine Kinase-MB	T059	C0523584
28062147	764	777	hs-Troponin I	T059	C0523952
28062147	793	801	measured	T080	C0444706
28062147	809	812	PCI	T061	C1532338
28062147	827	841	post-procedure	T079	C3272301
28062147	853	862	universal	T080	C0175671
28062147	863	873	definition	T170	C1704788
28062147	877	898	myocardial infarction	T047	C0027051
28062147	920	923	PMI	T047	C3839342
28062147	935	947	participants	T098	C0679646
28062147	956	974	inclusion criteria	T080	C1512693
28062147	984	992	analysed	T062	C0936012
28062147	997	1000	PMI	T047	C3839342
28062147	1008	1020	participants	T098	C0679646
28062147	1026	1030	male	T098	C0025266
28062147	1036	1044	mean age	T079	C0026062
28062147	1091	1103	participants	T098	C0679646
28062147	1118	1126	criteria	T078	C0243161
28062147	1131	1134	PMI	T047	C3839342
28062147	1148	1156	pinching	T037	C0418416
28062147	1172	1185	TIMI III flow	T033	C3272287
28062147	1208	1211	PMI	T047	C3839342
28062147	1219	1240	Duration of procedure	T079	C1442476
28062147	1252	1273	right coronary artery	T023	C0226042
28062147	1274	1286	intervention	T061	C0184661
28062147	1301	1319	total stent length	T081	C0449462
28062147	1349	1364	associated with	T080	C0332281
28062147	1365	1368	PMI	T047	C3839342
28062147	1370	1373	PMI	T047	C3839342
28062147	1374	1382	occurred	T052	C1709305
28062147	1412	1415	PCI	T061	C1532338
28062147	1425	1440	consistent with	T078	C0332290
28062147	1445	1455	prevalence	T081	C0220900
28062147	1459	1462	PMI	T047	C3839342
28062147	1487	1506	multicentre studies	T062	C1096776
28062147	1511	1519	required	T169	C1514873
28062147	1527	1545	demographic region	T090	C0011298
28062147	1564	1572	relevant	T080	C2347946
28062147	1573	1583	predictors	T078	C2698872
28062147	1588	1596	outcomes	T169	C1274040
28062147	1597	1612	associated with	T080	C0332281
28062147	1613	1616	PMI	T047	C3839342